Azilva Tops SOC Ranking for Second Month in a Row in November in Both Hospital and GP Markets: Anterio

According to Anterio Inc.’s “SOC (Share of Channels)” survey, which determines and ranks the ethical drug mind share among doctors by channel, Takeda Pharmaceutical’s angiotensin receptor blocker (ARB) Azilva (azilsartan) was the most promoted drug in both the GP (99...read more